AI Article Synopsis

  • The study analyzed risk factors for acute esophagitis (AE) in non-small-cell lung cancer (NSCLC) patients receiving 3D conformal radiotherapy.
  • Thirty-four out of 102 patients (33.3%) developed grade 2 or 3 AE, with factors like lymph node stage, pretreatment weight loss, concurrent chemotherapy, and dose volume parameters contributing to higher risk.
  • Concurrent chemotherapy, lymphatic status, and a specific radiation dose metric (rV55) were identified as key predictors for experiencing grade 2 or worse AE.

Article Abstract

Purpose: To analyze the clinical and dosimetric risk factors of acute esophagitis (AE) in non-small-cell lung cancer (NSCLC) patients treated with 3-dimensional conformal radiotherapy (3D-CRT).

Methods And Materials: One hundred two NSCLC patients treated with 3D-CRT were retrospectively analyzed. Forty of these 102 patients analyzed were treated with concurrent chemotherapy (CCT). The median biologic effective dose of radiotherapy was 72.0 Gy. AE was scored according to the Radiation Therapy Oncology Group criteria. The clinical and dosimetric factors associated with grade 2 or worse AE were analyzed using univariate and multivariate binary logistic analysis.

Results: There were no grade 4 or 5 AE observed in the 102 patients analyzed. Thirty-four of 102 patients (33.3%) developed grade 2 or 3 AE. Univariate analysis showed that clinical factors, such as lymph nodes stage (N 0/1 vs. N 2/3), pretreatment weight loss > or =5%, CCT, and the use of late-course hyperfractionated radiotherapy were significantly associated with grade 2 and 3 AE. Dose volume parameters of esophagus including mean esophageal dose, maximal esophageal dose, rV15, rV20, rV25, rV30, rV35, rV40, rV45, rV50, rV55, rV60 were also associated with AE. On multivariate forward step-wise logistic analysis, CCT, lymph nodes stage, and rV55 emerged as the statistically most significant factors of AE with OR parameters of 8.911, 4.832, and 1.083, respectively.

Conclusion: CCT, lymphatic status, and rV55 were strong predictors of grade 2 or worse AE in NSCLC treated with 3D-CRT.

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e3181a879e0DOI Listing

Publication Analysis

Top Keywords

clinical dosimetric
12
patients treated
12
102 patients
12
dosimetric risk
8
risk factors
8
factors acute
8
acute esophagitis
8
treated 3-dimensional
8
3-dimensional conformal
8
conformal radiotherapy
8

Similar Publications

Impact of diaphragm motion on dosimetry in lower thoracic spine stereotactic body radiotherapy.

Phys Med

January 2025

Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.

Background And Purpose: Free-breathing computed tomography (FBCT) used in treatment planning for lower thoracic (Th8-Th12) spine stereotactic body radiotherapy (SBRT) can cause deviations between planned and irradiated doses due to diaphragm movement (DM). This study analyzed the dosimetric impact of DM on lower thoracic spine SBRT.

Materials And Methods: Data were collected from 19 patients who underwent FBCT and four-dimensional CT (4DCT) during the same session.

View Article and Find Full Text PDF

Background: The combination of immune checkpoint inhibitors (ICIs) and radiotherapy (RT) may increase the risk of radiation esophagitis (RE). This study aimed to establish and validate a new nomogram to predict RE in patients with non-small cell lung cancer (NSCLC) undergoing immunochemotherapy followed by RT (ICI-RT).

Methods: The 102 eligible patients with NSCLC treated with ICI-RT were divided into training (n = 71) and validation (n = 31) cohorts.

View Article and Find Full Text PDF
Article Synopsis
  • Proton Minibeam Radiation Therapy has been promising in enhancing treatment efficacy compared to traditional radiation, but more research into its biological mechanisms is needed.
  • A mechanical collimation setup was developed to produce 250µm minibeams with a 1000µm spacing, with optimization using Monte Carlo simulations conducted at various proton therapy sites.
  • Results showed a peak-to-valley dose ratio (PVDR) of 10 in Dresden and 14 in Seattle, with some discrepancies between dosimetry methods that can be addressed with correction factors.
View Article and Find Full Text PDF

Technical Aspects of a National Service for Paediatric Pelvic Brachytherapy.

Clin Oncol (R Coll Radiol)

December 2024

Department of Oncology, University College London Hospitals NHS Foundation Trust, 250 Euston Road, London, NW1 2PG, UK. Electronic address:

Aims: Brachytherapy is advantageous for localised rhabdomyosarcomas in children compared with external beam radiotherapy, sparing close organs at risk with highly conformal dosimetry. A methodology for planning and delivering fractionated high-dose-rate paediatric pelvic brachytherapy is detailed, and the dosimetric parameters are presented. This provides a practical template for radiotherapy departments with a similar patient cohort to implement this treatment technique.

View Article and Find Full Text PDF

Dosimetric comparison of VMAT plans in preoperative short-course rectal radiotherapy.

Sci Rep

December 2024

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China.

Recently, neoadjuvant short-course radiation therapy (SCRT) has emerged as a valid treatment option for patients with locally advanced rectal cancer (LARC). We assessed SCRT plans using volumetric-modulated arc therapy (VMAT) with Halcyon and Infinity medical linear accelerators (Linacs) and compared the plan quality and delivery efficiency across all cases. Thirty patients who underwent preoperative SCRT for LARC at the hospital were randomly selected.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!